Healthcare delivery
A119 – A136
- A119: Abstract withdrawn
- A120: Does intensive follow-up of lung cancer patients improve survival?: a systematic review and meta-analysis
- A121: Abstract withdrawn
- A122: A qualitative synthesis of the use of complementary and alternative medicine after a diagnosis of cancer
- A123: The development and validation of a clinical prediction rule to aid general practitioners in identifying symptomatic patients at high risk of breast cancer
- A124: Factors influencing adjuvant treatment choices in stage I seminoma: the patients’ perspective
- A125: Patient preferences for colposcopy appointments
- A126: A narrative study of the experiences of young people from first symptoms to the diagnosis of cancer
- A127: Causes of death in patients diagnosed with cancer aged 15 to 24 years old in England, 1996 to 2005
- A128: Improving the patient experience and reducing length of stay - a novel approach to managing inpatients presenting with previously undiagnosed cancer
- A129: Trends in incidence of endometrial cancer in the West Midlands: 2000-2006
- A130: What does CNS stand for?
- A131: Use of imaging-based surveillance for post-operative management of stage I seminoma testis patients and the TRISST trial
- A132: Ethical issues of consent in pharmacogenomic research on cancer patients<
- A133: Evaluating the use of academic self-directed learning to assist cancer specialist nurses to develop new clinical skills
- A134: ‘Being a cancer patient doesn’t mean it stops when you walk out the hospital.’ Patients’ and stakeholder perspectives of ‘Surviving Cancer, Living Life’ telephone care management programme
- A135: Fatal reaction to Paclitaxel (P) challenge after hypersensitivity reaction (HSR) to Docetaxel (D)
- A136: The development and preliminary application of a measure to describe the quality of cancer MDT meetings
